Agoracom: Small Cap Investment - POET Technologies Inc. - Re: OT – An example of how hard a biotech can get hit.

Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Reply New Message

Prev Message Back To Forum Threaded View Next Message

cheapinski

Rank: Treasurer [?]

Points: 5471 [?]

Votes: 205 Score: 2.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: OT – An example of how hard a biotech can get hit.

in response to

OT – An example of how hard a biotech can get hit.

fairchij

posted on Oct 25, 2013 11:01AM

I have similar stories (although not quite as sexy!) about pharmas.....the phaseIII is very tough and long and its easy to get discouraged while you wait the 3 years or so to get results...then you need to get FDA approval to market in the States and thats even tougher sometimes.

We seem to have a tighter timeline with a semi-definite endpoint. Much easier to live with. Thx for that Fairchij.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply